About James Goater, Jr.
Form D filings for Topo Therapeutics in 2024 list James Goater, Jr. as director.
James Goater, Jr. first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name James Goater, Jr. in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people James Goater, Jr. works with at each company, as listed on that company's latest Form D.
Topo Therapeutics, Inc. · Form D/A, Dec 31, 2024
BB
Bruce Bean
Director
HT
Hui Tian
Executive officer and director
MM
Madgalene Moran
Chief Executive Officer and director
KK
Karin Kleinhans
Director